Anticoagulants: dose control methods and inhibitors
نویسندگان
چکیده
These days, anticoagulants are in great demand. They used as a prophylaxis for thromboembolic complications various diseases and conditions general therapeutic practice, cardiology, neurology, well obstetrics to manage high-risk pregnancies. The relevance of competent use has come the fore connection with emergence new disease – COVID-19 its serious such developing thrombotic storm, which timely applied anticoagulant therapy is key success therapy. risk bleeding should be considered when using any anticoagulant. Age, impaired renal function concomitant antiplatelet agents common factors bleeding. Moreover, only vitamin K antagonists heparin have specific antidotes protamine, respectively. Inhibitors other universal presented inactivated or activated prothrombin complex concentrate recombinant factor VIIa. Hemodialysis effectively reduces dabigatran concentration, charcoal effective case recent oral administration lipophilic drugs. Research on currently available under way, similar testing types that sufficiently preventing treating minimal hemorrhagic. main contraindication doctor's ignorance mechanisms drug action opportunities suppressing effect.
منابع مشابه
Minimizing the risks of anticoagulants and platelet inhibitors.
Thrombosis is a major contributor to the adverse outcomes associated with atherosclerotic disease. Acute coronary syndromes (ACS) result when intravascular thrombosis occurs at the site of an atherosclerotic plaque rupture. In this setting, the use of anticoagulants and platelet inhibitors is life-saving, but these agents also contribute additional risks for bleeding. The risks and benefits of ...
متن کاملFactor Xa inhibitors--new anticoagulants for secondary haemostasis.
Oral factor Xa (FXa) inhibitors are a promising alternative to current anticoagulants. This paper reviews the latest developments of oral direct FXa inhibitors and focuses on those which have been approved for the prevention of venous thromboembolism (VTE) after total hip or knee replacement or are in advanced development and have passed phase II (proof of principle) testing. The most advanced ...
متن کامل[New anticoagulants for secondary haemostasis--anti IIa inhibitors].
In contrast to heparins and oral anticoagulants, anti IIa inhibitors (thrombin inhibitors) are able to directly inhibit the protease activity of thrombin and can thereby precisely control the blood coagulation process. Direct thrombin inhibitors are either biosimilars (r-hirudin) or synthetically produced substances (bivalirudin, argatroban, dabigatran). In 1997 r-hirudin was introduced into cl...
متن کاملFactor IXa Inhibitors as Novel Anticoagulants R1 Howard Factor IXa Inhibitors
Currently available anticoagulants are limited by modest therapeutic benefits, narrow clinical applications, increased bleeding risk, and drug-induced thrombophilia. Because factor IX plays a pivotal role in thrombin generation, it may represent a promising target for drug development. Several methods of attenuating factor IX activity, including monoclonal antibodies, synthetic active site-bloc...
متن کاملDose Reduction Methods in Chest Computed Tomography
Introduction: Computed tomography is one of the most powerful tools for investigating thorax disease, because it shows progression of lung disease much clearer than chest radiography. Technical advances in CT scanners have led to some abilities for CT scanners such as coverage of larger volume, lower noise and ability for acquiring image in one respiratory phase. However, this will be accompani...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Obstetrics, Gynecology and Reproduction
سال: 2022
ISSN: ['2313-7347', '2500-3194']
DOI: https://doi.org/10.17749/2313-7347/ob.gyn.rep.2022.293